Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development - PubMed (original) (raw)
Comparative Study
Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development
A J Buckler et al. Mol Cell Biol. 1991 Mar.
Abstract
The human Wilms' tumor predisposition gene, WT1, is a Cys-His zinc finger polypeptide which appears to be a transcription factor controlling gene expression during embryonic kidney development. In order to analyze the role of the WT1 gene in nephroblast differentiation, we have isolated the murine homolog of human WT1. An extremely high level of amino acid sequence conservation (greater than 95%) extends throughout all regions of the predicted mouse and human WT1 polypeptides. Two alternative splices within the WT1 transcript have been conserved between mice and humans, suggesting that these have functional significance. Expression of the mouse WT1 mRNA in fetal kidney increases during late gestation, peaks just prior to or shortly after birth, and declines dramatically by 15 days postpartum. Developmental regulation of WT1 expression appears to be selective for the kidney. The restriction of WT1 expression to a limited number of tissues is in contrast to previously described tumor suppressor genes. In addition, the narrow window of time during which WT1 is expressed at high levels in the kidney is consistent with the origin of Wilms' tumor from primitive nephroblasts and the postulated role of this gene as a negative regulator of growth.
Similar articles
- Expression of the Wilms' tumor gene WT1 in the murine urogenital system.
Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D. Pelletier J, et al. Genes Dev. 1991 Aug;5(8):1345-56. doi: 10.1101/gad.5.8.1345. Genes Dev. 1991. PMID: 1651275 - Alternative splicing and genomic structure of the Wilms tumor gene WT1.
Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Haber DA, et al. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9618-22. doi: 10.1073/pnas.88.21.9618. Proc Natl Acad Sci U S A. 1991. PMID: 1658787 Free PMC article. - Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.
Gessler M, König A, Moore J, Qualman S, Arden K, Cavenee W, Bruns G. Gessler M, et al. Genes Chromosomes Cancer. 1993 Jul;7(3):131-6. doi: 10.1002/gcc.2870070304. Genes Chromosomes Cancer. 1993. PMID: 7687865 - Role of the WT1 gene in Wilms' tumour.
Haber DA, Housman DE. Haber DA, et al. Cancer Surv. 1992;12:105-17. Cancer Surv. 1992. PMID: 1322241 Review. - WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
Haber DA, Buckler AJ. Haber DA, et al. New Biol. 1992 Feb;4(2):97-106. New Biol. 1992. PMID: 1313285 Review.
Cited by
- WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.
Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG, Garvin AJ, Rosner MR, Haber DA. Englert C, et al. EMBO J. 1995 Oct 2;14(19):4662-75. doi: 10.1002/j.1460-2075.1995.tb00148.x. EMBO J. 1995. PMID: 7588596 Free PMC article. - T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors.
Tsimberidou AM, Van Morris K, Vo HH, Eck S, Lin YF, Rivas JM, Andersson BS. Tsimberidou AM, et al. J Hematol Oncol. 2021 Jun 30;14(1):102. doi: 10.1186/s13045-021-01115-0. J Hematol Oncol. 2021. PMID: 34193217 Free PMC article. Review. - A review of the genetic background in complicated WT1-related disorders.
Nagano C, Nozu K. Nagano C, et al. Clin Exp Nephrol. 2024 Jul 13. doi: 10.1007/s10157-024-02539-x. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 39002031 Review. - Compilation of vertebrate-encoded transcription factors.
Faisst S, Meyer S. Faisst S, et al. Nucleic Acids Res. 1992 Jan 11;20(1):3-26. doi: 10.1093/nar/20.1.3. Nucleic Acids Res. 1992. PMID: 1738600 Free PMC article. No abstract available. - WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study.
Netinatsunthorn W, Hanprasertpong J, Dechsukhum C, Leetanaporn R, Geater A. Netinatsunthorn W, et al. BMC Cancer. 2006 Apr 11;6:90. doi: 10.1186/1471-2407-6-90. BMC Cancer. 2006. PMID: 16606472 Free PMC article.
References
- N Engl J Med. 1964 Apr 30;270:922-7 - PubMed
- Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3 - PubMed
- Hum Hered. 1987;37(2):94-101 - PubMed
- Nature. 1986 Oct 16-22;323(6089):643-6 - PubMed
- Genomics. 1988 Jul;3(1):25-31 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases